Safety and immunogenicity of a highly attenuated rVSVN4CT1-EBOVGP1 Ebola virus vaccine: a randomised, double-blind, placebo-controlled, phase 1 clinical trial

David K Clarke; Rong Xu; Demetrius Matassov; Theresa E Latham; Ayuko Ota-Setlik; Cheryl S Gerardi; Amara Luckay; Susan E Witko; Luz Hermida; Terry Higgins; Marc Tremblay; Susan Sciotto-Brown; Tracy Chen; Michael A Egan; Janice M Rusnak; Lucy A Ward; John H Eldridge

doi:10.1016/s1473-3099(19)30614-0

Safety and immunogenicity of a highly attenuated rVSVN4CT1-EBOVGP1 Ebola virus vaccine: a randomised, double-blind, placebo-controlled, phase 1 clinical trial

The Lancet Infectious Diseases ◽

10.1016/s1473-3099(19)30614-0 ◽

2020 ◽

Vol 20 (4) ◽

pp. 455-466 ◽

Cited By ~ 3

Author(s):

David K Clarke ◽

Rong Xu ◽

Demetrius Matassov ◽

Theresa E Latham ◽

Ayuko Ota-Setlik ◽

...

Keyword(s):

Clinical Trial ◽

Virus Vaccine ◽

Ebola Virus ◽

Phase 1 ◽

Double Blind ◽

Double Blind Placebo ◽

Phase 1 Clinical Trial

Download Full-text

Use of ChAd3-EBO-Z Ebola virus vaccine in Malian and US adults, and boosting of Malian adults with MVA-BN-Filo: a phase 1, single-blind, randomised trial, a phase 1b, open-label and double-blind, dose-escalation trial, and a nested, randomised, double-blind, placebo-controlled trial

The Lancet Infectious Diseases ◽

10.1016/s1473-3099(15)00362-x ◽

2016 ◽

Vol 16 (1) ◽

pp. 31-42 ◽

Cited By ~ 120

Author(s):

Milagritos D Tapia ◽

Samba O Sow ◽

Kirsten E Lyke ◽

Fadima Cheick Haidara ◽

Fatoumata Diallo ◽

...

Keyword(s):

Virus Vaccine ◽

Ebola Virus ◽

Controlled Trial ◽

Phase 1 ◽

Randomised Trial ◽

Open Label ◽

Double Blind ◽

Double Blind Placebo ◽

Phase 1B ◽

Single Blind

Download Full-text

LBP-25-a phase 1 clinical trial of therapeutic vaccine t101 in chronic hepatitis b (chb) patients: a randomized, double-blind, placebo-controlled, single and multiple injections, dose escalation study

Journal of Hepatology ◽

10.1016/s0618-8278(19)30271-3 ◽

2019 ◽

Vol 70 (1) ◽

pp. e153-e154 ◽

Cited By ~ 2

Author(s):

Yue Hu ◽

Xiaomin WANG ◽

zhiming wang ◽

dong gao ◽

lan zhang ◽

...

Keyword(s):

Clinical Trial ◽

Chronic Hepatitis ◽

Hepatitis B ◽

Dose Escalation ◽

Phase 1 ◽

Therapeutic Vaccine ◽

Dose Escalation Study ◽

Double Blind ◽

Double Blind Placebo ◽

Phase 1 Clinical Trial

Download Full-text

Safety and immunogenicity of a quadrivalent inactivated subunit non-adjuvanted influenza vaccine: A randomized, double-blind, active-controlled phase 1 clinical trial

Vaccine ◽

10.1016/j.vaccine.2021.05.070 ◽

2021 ◽

Author(s):

Yanxia Wang ◽

Yuhui Zhang ◽

Haofei Wu ◽

Lili Huang ◽

Hailong Yu ◽

...

Keyword(s):

Clinical Trial ◽

Influenza Vaccine ◽

Phase 1 ◽

Double Blind ◽

Phase 1 Clinical Trial

Download Full-text

Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy adults aged 60 years and older: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial

The Lancet Infectious Diseases ◽

10.1016/s1473-3099(20)30987-7 ◽

2021 ◽

Cited By ~ 11

Author(s):

Zhiwei Wu ◽

Yaling Hu ◽

Miao Xu ◽

Zhen Chen ◽

Wanqi Yang ◽

...

Keyword(s):

Clinical Trial ◽

Phase 1 ◽

Healthy Adults ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Safety and Immunogenicity of Inactivated Varicella-Zoster Virus Vaccine in Adults With Autoimmune Disease: A Phase 2, Randomized, Double-Blind, Placebo-Controlled Clinical Trial

Clinical Infectious Diseases ◽

10.1093/cid/cix484 ◽

2017 ◽

Vol 65 (7) ◽

pp. 1174-1182 ◽

Cited By ~ 15

Author(s):

Michael Eberhardson ◽

Stephen Hall ◽

Kim A Papp ◽

Tina M Sterling ◽

Jon E Stek ◽

...

Keyword(s):

Clinical Trial ◽

Autoimmune Disease ◽

Varicella Zoster Virus ◽

Virus Vaccine ◽

Controlled Clinical Trial ◽

Phase 2 ◽

Double Blind ◽

Double Blind Placebo ◽

Varicella Zoster ◽

Varicella Zoster Virus Vaccine

Download Full-text

Safety and immunogenicity of the rVSV∆G-ZEBOV-GP Ebola virus vaccine candidate in healthy adults: a phase 1b randomised, multicentre, double-blind, placebo-controlled, dose-response study

The Lancet Infectious Diseases ◽

10.1016/s1473-3099(17)30313-4 ◽

2017 ◽

Vol 17 (8) ◽

pp. 854-866 ◽

Cited By ~ 51

Author(s):

D Gray Heppner ◽

Tracy L Kemp ◽

Brian K Martin ◽

William J Ramsey ◽

Richard Nichols ◽

...

Keyword(s):

Virus Vaccine ◽

Dose Response ◽

Ebola Virus ◽

Vaccine Candidate ◽

Healthy Adults ◽

Double Blind ◽

Double Blind Placebo ◽

Phase 1B ◽

Dose Response Study

Download Full-text

Preliminary aggregate safety and immunogenicity results from three trials of a purified inactivated Zika virus vaccine candidate: phase 1, randomised, double-blind, placebo-controlled clinical trials

The Lancet ◽

10.1016/s0140-6736(17)33106-9 ◽

2018 ◽

Vol 391 (10120) ◽

pp. 563-571 ◽

Cited By ~ 100

Author(s):

Kayvon Modjarrad ◽

Leyi Lin ◽

Sarah L George ◽

Kathryn E Stephenson ◽

Kenneth H Eckels ◽

...

Keyword(s):

Clinical Trials ◽

Virus Vaccine ◽

Zika Virus ◽

Vaccine Candidate ◽

Phase 1 ◽

Controlled Clinical Trials ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Immunogenicity of chimeric haemagglutinin-based, universal influenza virus vaccine candidates: interim results of a randomised, placebo-controlled, phase 1 clinical trial

The Lancet Infectious Diseases ◽

10.1016/s1473-3099(19)30393-7 ◽

2020 ◽

Vol 20 (1) ◽

pp. 80-91 ◽

Cited By ~ 34

Author(s):

David I Bernstein ◽

Jeffrey Guptill ◽

Abdollah Naficy ◽

Raffael Nachbagauer ◽

Francesco Berlanda-Scorza ◽

...

Keyword(s):

Clinical Trial ◽

Influenza Virus ◽

Virus Vaccine ◽

Phase 1 ◽

Influenza Virus Vaccine ◽

Vaccine Candidates ◽

Phase 1 Clinical Trial

Download Full-text

Safety, Tolerability, and Immunogenicity of a SARS-CoV-2 Recombinant Spike RBD Protein Vaccine: A Randomised, Double-Blind, Placebo-Controlled, Phase 1-2 Clinical Trial (ABDALA Study)

SSRN Electronic Journal ◽

10.2139/ssrn.4000556 ◽

2022 ◽

Author(s):

Francisco Hernández-Bernal ◽

Maria del Carmen Ricardo-Cobas ◽

Yenima Martín-Bauta ◽

Zadis Navarro-Rodríguez ◽

Marjoris Piñera-Martínez ◽

...

Keyword(s):

Clinical Trial ◽

Phase 1 ◽

Protein Vaccine ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial

The Lancet Infectious Diseases ◽

10.1016/s1473-3099(20)30843-4 ◽

2020 ◽

Cited By ~ 11

Author(s):

Yanjun Zhang ◽

Gang Zeng ◽

Hongxing Pan ◽

Changgui Li ◽

Yaling Hu ◽

...

Keyword(s):

Clinical Trial ◽

Phase 1 ◽

Healthy Adults ◽

Double Blind ◽

Double Blind Placebo

Download Full-text